Ultra V leads the Middle East Market with K-Beauty

“UltraCol” has secured product registration in Jordan... High demand for aesthetic medical in the Arab world raises growth expectations in related fields

​

The bio-medical beauty group of UltraV (CEO Han-jin Kwon) announced that its uniquely patented technology developed 'UltraCol’ has recently secured product registration (UltraCol 100 & 200) in Jordan.

Jordan ranks third among Middle East countries in terms of demand for cosmetic surgery relative to its population. Recently rising interest in aesthetics, the market for related aesthetic medical products such as Botox, fillers and treatment devices is gradually expanding.

Additionally, Jordan not only has traditionally been a medical tourism destination, but also is also a country that is expected to continue to grow in the field, combined with aesthetic medical needs of both Jordanians and Arabs from neighboring countries.

​

With this product registration, 'UltraCol' officially be exported to Jordan through an official local distributor. With the rapid growth of the local aesthetic medical device market, it is expected to secure high marketability and accelerate the expansion of the Middle East market.

Last year, 'UltraCol' has secured product registration in Kuwait and is now leading the domestic and international K-Beauty markets by registering products not only in the Middle East but also in Asia, South America and Europe.

An official from Ultra V stated, "We expect that the approval of 'UltraCol' for product registration in Jordan will accelerate our market share expansion in the Middle East and. and we will continue to aggressively market our products to dominate the global aesthetic medical market and will consistently strive to expand our influence in international markets.”

Meanwhile, Ultra V is focused on leading the aesthetic medical market in the Middle East, following its success in Asia, South America, and Europe, as it continues to expand its presence in the global market.